Understanding Myelodysplastic Syndrome (MDS)

Created using ChatSlide

Myelodysplastic Syndromes (MDS) involve mutated stem cells leading to ineffective blood production, resulting in symptoms like fatigue and infections. Diagnosis includes CBC, bone marrow biopsy, and cytogenetics to assess risk and potential progression to Acute Myeloid Leukemia (AML). Management strategies focus on supportive care, including transfusions, and targeted treatments such as EPO and azacitidine, with stem cell transplant being the primary curative option.